The GNL Podcast Episode 17, GLP-1 in Type 1 Diabetes A person who has dosed insulin every day for years sits across from a clinician and asks a quieter question than usual: not how to fix the next high, but whether insulin alone was ever going to be enough
Genetic approaches to analyzing mitochondrial outer membrane permeability
See Individuals Tests See Individual Tests Test Code(s): 5193, 5194 Biomarkers Tested (55): Albumin ALBUMIN/GLOBULIN RATIO Alkaline Phosphatase ALT ALT (SGPT) AST AST (SGOT) Baso (Absolute) Basophils Bilirubin, Total BUN BUN/Creatinine Ratio Calcium Carbon Dioxide, Total Chloride Chol/HDLC Ratio Cholesterol, Total Creatinine eAG eGFR Eos Eos (Absolute) Estim
Tirzepatide Once Weekly for the Treatment of Obesity New England Journal of Medicine 387(3) 2022PMID: 35658024 NEJM 3 Drucker DJ Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 Cell Metabolism 27(4) 2018PMID: 29617641 PubMed 4 Lincoff AM, Brown-Frandsen K, Colhoun HM, et al
Most practitioners initiate patients at 1 mL weekly during the first 4 to 8 weeks of GLP-1 therapy, then reassess tolerability and energy levels before advancing to 2 mL or increased frequency
They can be expensive, and not all insurance plans provide coverage, causing patients to stop taking them